Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-17-000590
Filing Date
2017-01-30
Accepted
2017-01-30 17:04:59
Documents
4
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT aols_10ka.htm 10-K/A 725218
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF aols_ex311.htm EX-31.1 10965
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF aols_ex312.htm EX-31.2 11356
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE aols_ex321.htm EX-32.1 10138
  Complete submission text file 0001654954-17-000590.txt   758893
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-50481 | Film No.: 17558287
SIC: 2834 Pharmaceutical Preparations